KR890003677B1 - Method for preparing hyaluronic acid by microorganism - Google Patents
Method for preparing hyaluronic acid by microorganism Download PDFInfo
- Publication number
- KR890003677B1 KR890003677B1 KR1019870008243A KR870008243A KR890003677B1 KR 890003677 B1 KR890003677 B1 KR 890003677B1 KR 1019870008243 A KR1019870008243 A KR 1019870008243A KR 870008243 A KR870008243 A KR 870008243A KR 890003677 B1 KR890003677 B1 KR 890003677B1
- Authority
- KR
- South Korea
- Prior art keywords
- hyaluronic acid
- culture
- cell
- glucose
- fermenter
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
제1도는 본 발명에 이용되는 반복 유가 배양의 모식도.1 is a schematic diagram of repeated fed-batch cultivation used in the present invention.
* 도면의 주요부분에 대한 부호의 설명* Explanation of symbols for main parts of the drawings
1 : 발효조 2 : 배지저장조1
3 : 포도당저장조 4,8,9 : 펌프3: glucose storage tank 4,8,9 pump
5 : pH조절장치 6 : 원삼분리기5: pH control device 6: Wonsam separator
7 : 히아론산7: hyaluronic acid
본 발명은 고농도의 히아론산(Hyaluronic acid)을 얻기 위한 새로운 미생물 배양방법에 관한 것이다.The present invention relates to a new microbial culture method for obtaining a high concentration of hyaluronic acid (Hyaluronic acid).
히아론산은 소의 안구, 닭벼슬, 동물의 간충조직, 태반이나 암세포, 피부등에 널리 분포되어 있다.Hyaluronic acid is widely distributed in cow's eye, chicken rice, animal hepatitis, placenta and cancer cells, and skin.
히아론산은 단백질과 결합체를 형성하여 젤리 상태로되어 물리적 마찰에 대한 윤활효과 및 세균등의 침입에 대한 보호효과가 있고 보습성이 있어 피부보호제로 이용된다.Hyaluronic acid forms a conjugate with protein and becomes a jelly state, which has a lubricating effect against physical friction and a protective effect against invasion of bacteria, etc., and is used as a skin protection agent because of its moisturizing properties.
히아론산을 얻기 위해서 종래에는 사람의 태반, 닭벼슬 돼지가죽등에 함유된 것을 추출법에 의하여 얻었다. 이때 얻어진 히아론산에는 불순물, 즉 콘드리아친 설페이트, 글리코사이노 글리칸 설페이트 등이 다량으로 혼입되어 이들을 제거하기 위하여 고순도로 정제할 필요가 있어 생산 비용이 매우 높았다.In order to obtain hyaluronic acid, what was conventionally contained in human placenta, chicken rice, pig skin, etc. was obtained by the extraction method. The hyaluronic acid obtained at this time was mixed with a large amount of impurities, namely, chondriacin sulfate, glycosino glycan sulfate, and the like, and it was necessary to purify them with high purity in order to remove them.
반면에 근래에는 발효법에 의한 기술이 개발되어 연쇄상구균인 스트랩토 코커스 속의 파이오제네스, 이퀴, 쥬에피데미큐스 등의 미생물을 배양하여 히아론산을 제조하는 방법이 연구되었다.(J. Biol. Chem. 244,236-246(1969), 일본특허공보 58-56692(1983), Ger offen. DE 3,517,659(1985)) 이들 방법은 화분식으로써 일반적으로 생산 수율이 낮을 뿐 아니라, 시간과 설비의 효율적 이용이 어려운 단점이 있었다. 반면에 반복식 유가배양 방법은 세포는 일정한 간격을 두고 발효조에 재 충입하고 여액만 수거하여 매우 높은 농도의 히아론산을 얻을 수 있다. 이에 본 발명자들은 반복식 유가배양에 의한 배양방법을 도입함으로써 종래의 회분식에서 보다 10배의 고농도로 히아론산을 얻을 수 있었다. 본 발명에 사용한 히아론산의 생산방법을 상세히 설명하면 다음과 같다.On the other hand, in recent years, a fermentation technique has been developed, and a method of producing hyaluronic acid by culturing microorganisms such as pyogenes, Equi, and Jupitemicus in Streptococcus, Streptococcus, has been studied. (J. Biol. Chem. 244,236-246 (1969), Japanese Patent Application Laid-Open No. 58-56692 (1983), Ger offen.DE 3,517,659 (1985)) These methods are potted, and generally have low production yields and are difficult to use time and equipment efficiently. There was this. On the other hand, in the repetitive fed-batch method, cells can be recharged into the fermenter at regular intervals and only the filtrate is collected to obtain very high concentration of hyaluronic acid. Therefore, the present inventors have been able to obtain hyaluronic acid at a higher concentration of 10 times than in a conventional batch type by introducing a cultivation method by repeating fed-batch culture. Referring to the production method of hyaluronic acid used in the present invention in detail.
사용균주는 스트랩토코커스 이퀴 KCTC1873균주로써 종배양은 2.5%의 비일 인퓨전브로쓰를 사용하였다. 비교 실시예와 같은 조성의 배양액에 종균을 접종하여 pH, 7.0-7.5, 온도 30-37℃, 통기량 0.1-1.0VVM을 유지하면서 12-15시간 배양한다. 이때 배양액내의 세포는 후 대수기(late log)의 상태이고 많은 히아론산을 생성하는 반면, 세포성장인자(growth factor)의 고갈로 인하여 세포성장이 정지하려는 상태이다.The strain used was Straptococcus Equi KCTC1873 strain, and the seed culture was 2.5% Biyl Infusion Broth. The seed was inoculated into the culture medium having the same composition as the comparative example, and cultured for 12-15 hours while maintaining pH, 7.0-7.5, temperature 30-37 ° C., and aeration of 0.1-1.0 VVM. At this time, the cells in the culture medium is in the late log phase (late log) state and produce a lot of hyaluronic acid, the cell growth factor (growth factor) due to the depletion of the cell growth is a state to stop.
이때 배양액을 수거하여 세포만을 선별적으로 발효조내에 재충입하고, 신선한 배지를 일정한 간격을 두고 연속적으로 주입하면 성장인자의 재유입으로 인해 세포는 계속 성장하여발효조내의 세포농도가 매우 높게 된다. 아울러 히아론산도 발효조내에 고농도로 농축된다. 또한, 각 배양 단계마다 히아론산의 최초 기질이 되는 포도당을 발효조내에 일정한 수준(3-6%(W/V))으로 유지해 주면 더욱 많은 히아론산이 축적된다. 이와 같이 세포 성장인자의단계적 공급 및 포도당을 주기적으로 공급하는 반복식 화분배양 및 반복식 유가 배양에 의해 고농도의 히아론산을 얻었다.At this time, the culture medium is collected, and only the cells are selectively refilled into the fermenter, and the fresh medium is continuously injected at regular intervals, and the cells continue to grow due to the influx of growth factors, thereby increasing the cell concentration in the fermenter. Hyaluronic acid is also concentrated in high concentrations in fermenters. In addition, if the glucose, which is the initial substrate of hyaluronic acid, is maintained at a constant level (3-6% (W / V)) in each fermentation step, more hyaluronic acid accumulates. Thus, high concentration of hyaluronic acid was obtained by the stepwise feeding of cell growth factors and the repetitive pollen culture and the repetitive fed-batch cultivation which supply glucose periodically.
위의 방법에 의해 매12-15시간마다 배양한 배양액을 수거하여 원심분리한 다음 세포 고형분만 발효조내로 재충입한다. 아울러 신선한 배지를 더불어 충입하는 조작을 4-5회 반복한 다음 60%의 포도당 용액을 펌프를 이용하여 배양액내로 서서히 주입하여 배양액재의 포도당 농도를 일정한 수준으로 유지하였다.The culture medium cultured every 12-15 hours by the above method is collected and centrifuged, and only the cell solids are refilled into the fermenter. In addition, the operation of refilling with fresh medium was repeated 4-5 times, and then 60% glucose solution was slowly injected into the culture medium using a pump to maintain the glucose concentration of the culture material at a constant level.
위의 조작을 배양액내의 히아론산 농도가 10.0g/ℓ가 되도록 수회 반복하였다.The above operation was repeated several times so that the concentration of hyaluronic acid in the culture was 10.0 g / l.
[비교실시예]Comparative Example
트립톤 1.5%, 펩톤 0.5%, 이스트엑기스 0.1%, 식염 및 인산 완충용액이 함유된 배지 9ℓ를 용량 14ℓ인 발효조에 충입하고 121℃에서 40분간 증기 멸균한 후 실온으로 냉각한 다음 따로 멸균한 포도당 용객 1ℓ를 최종농도 4%가 되도록 첨가하고 37℃에서 12시간 동안 2.5% 비일인퓨젼 브로쓰에서 배양한 스트랩토코커스이퀴(KCTC 1873)의 종배양액 100mℓ을 접중하여 통기량을 0.1VVM으로 주입하고 pH조절장치로 pH 7.0을 유지하면서 25-30시간 배양하였다.9 l of medium containing tryptone 1.5%, peptone 0.5%, yeast extract 0.1%, saline and phosphate buffer solution was charged to a fermenter with a volume of 14 l, steam sterilized at 121 ° C. for 40 minutes, cooled to room temperature, and then sterilized separately. 1 liter of solution was added to a final concentration of 4%, and aeration volume was injected at 0.1 VVM by contacting 100 ml of the seed culture medium of Straptococcus quick (KCTC 1873) incubated in 2.5% Bi-Infusion Broth at 37 ° C for 12 hours. 25-30 hours were incubated while maintaining pH 7.0 with a pH adjuster.
이와 같은 방법에 의하여 배양하여 공지의 방법으로 정량 분석하였던바 3.0g/ℓ의 세포건조 중량 및 1.5g/ℓ의 히아론산을 얻었다.By culturing in this manner and quantitatively analyzed by a known method, 3.0 g / L of cell dry weight and 1.5 g / L of hyaluronic acid were obtained.
[실시예 1]Example 1
비교실시예에서와 같은 배지가 저장된 배지저장조(2)로부터 펌프(4)를 이용하여 용량 14ℓ의 발효조(1)에 배지 9ℓ를 충입한 다음 비교실시예에서 같이 멸균, 냉각한 다음 포도당 저장조(3)의 포도당 용액을 펌프(8)를 이용하여 발효조(1)로 보내 초기 포도당 농도를 6%로 유지하고 비교실시예에서와 같은 종배양액을 접종하고 통기량 0.1VVM으로 통기하면서 pH 조절장치(5)로 pH를 7.0을 유지하면서 12-15시간 배양 후 배양액을 펌프(9)를 이용하여 수거하여 원삼분리기(6)로 원삼분리하여 상등액을 버리고 세포의 고형분만 발효조(1)내로 재충입하고 신선한 배지를 무균적 동량 첨가하여 배양하였다. 이와 같은 조작을 수회 되풀이하는 반복식 회분 배양에 의해 총 발효시간이 140-150시간이 되도록 하였던바 15.0g/ℓ의 세포 건조 중량 및 6.0g/ℓ의 히아론산을 얻었다.9 liters of medium was charged into a fermenter 1 having a capacity of 14 liters using a pump 4 from the
[실시예 2]Example 2
전술한 실시예 1의 방법에서 반복 회분식 배양을 하면서 배양시작 후 78시간이 경과하였을 때, 따로 멸균된 60%의 포도당 용액을 200mℓ/hr의 속도로 3시간 주입하고, 이후로 매 배치(batch)마다 배양 시작 후 6시간이 경과하였을 때 포도당 용액을 주입 하였던바 20.0g/ℓ의 세포 건조 중량 및 8.5g/ℓ의 히아론산을 얻었다.In the method of Example 1 described above, when 78 hours have passed since the start of the cultivation with the repeated batch culture, a sterilized 60% glucose solution was injected at a rate of 200 ml / hr for 3 hours, and then every batch. After 6 hours after the start of each culture, the glucose solution was injected to obtain a cell dry weight of 20.0 g / L and hyaluronic acid of 8.5 g / L.
[실시예 3]Example 3
전술한 실시예1의 방법에서 반복 회분식 배양을 하면서 배양시작후 24시간이 경화하였을때 따로 멸균된 60%의 포도당 용액을 배양액 내의 포도당 농도가 3-6%로 유지되도록 주입 하였던바 24.0g/ℓ의 세포 건조 중량 및 10.0g/ℓ의 히아론산을 얻었다.In the method of Example 1 described above, when 24 hours after the start of the incubation with repeated batch culture, a sterilized 60% glucose solution was injected to maintain the glucose concentration in the culture solution at 3-6%. 24.0 g / L Cell dry weight and 10.0 g / l hyaluronic acid were obtained.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870008243A KR890003677B1 (en) | 1987-07-29 | 1987-07-29 | Method for preparing hyaluronic acid by microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870008243A KR890003677B1 (en) | 1987-07-29 | 1987-07-29 | Method for preparing hyaluronic acid by microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890002387A KR890002387A (en) | 1989-04-10 |
KR890003677B1 true KR890003677B1 (en) | 1989-09-30 |
Family
ID=19263363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870008243A KR890003677B1 (en) | 1987-07-29 | 1987-07-29 | Method for preparing hyaluronic acid by microorganism |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890003677B1 (en) |
-
1987
- 1987-07-29 KR KR1019870008243A patent/KR890003677B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR890002387A (en) | 1989-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4801539A (en) | Fermentation method for producing hyaluronic acid | |
CN102268402A (en) | Serum free medium and culture method for high expression of erythropoietin in CHO (Chinese hamster ovary) cells | |
Pate et al. | Asticcacaulis biprosthecum sp. nov. Life cycle, morphology and cultural characteristics | |
CA1277618C (en) | Bacteriolytic enzyme product from streptomyces, a process for its preparation, and a strain suitable for this purpose | |
US4443545A (en) | Process for producing heparinase | |
KR890003677B1 (en) | Method for preparing hyaluronic acid by microorganism | |
EP0256423B1 (en) | Strain mass-producing epsilon-poly-l-lysine, a method for using its strain and a method for producing epsilon-poly-l-lysine | |
AU654488B2 (en) | Proteinaceous compositions from filamentous microorganisms, the branching of which is regulated by calcium ion concentration | |
US5294552A (en) | Strain mass-producing ε-poly-L-lysine | |
US5447856A (en) | Method for the production of trehalose using strains of Micrococcus and Deinococcus | |
DE112017002181T5 (en) | Bacterial strain and method for high throughput of sugar in microbial conversion to biosynthetic products | |
US3686072A (en) | L-asparaginase from erwinia | |
KR880001947B1 (en) | Process for preparing hyaluronic acid by circulating cell culture | |
KR880001948B1 (en) | Process for preparing hyaluronic acid by chemdstat culture | |
JP2001517429A (en) | Fermentation method for producing valuable biological substances using continuous mass culture of ciliates (protozoa) | |
EP0323717A2 (en) | Process for the production of microbial cellulose | |
RU2061751C1 (en) | Strain of yeast candida ethanolica - a producer of biomass | |
CN115287314B (en) | Process for fermenting and amplifying acid | |
CN112391431B (en) | Fermentation medium and fermentation method for recombinant leukocyte inhibitory factor and hirudin chimeric protein | |
JPH11221092A (en) | Production of erythritol | |
KR890001127B1 (en) | Producing method for oligo-fructose | |
KR900007000B1 (en) | Novel candida utilis and process for production of protein | |
US3843445A (en) | Asparaginase production | |
KR880001949B1 (en) | Process for preparing hyaluronic acid | |
SU1014881A1 (en) | Method for preparing biomass of e coli t |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20011231 Year of fee payment: 14 |
|
LAPS | Lapse due to unpaid annual fee |